Holen Sie sich die Stockscreener-App
62.28
0.56%
-0.3522
Handel nachbörslich:
61.98
-0.2995
-0.48%
Schlusskurs vom Vortag:
$62.63
Offen:
$62.19
24-Stunden-Volumen:
7,116
Relative Volume:
0.88
Marktkapitalisierung:
$281.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.19%
1M Leistung:
+5.47%
6M Leistung:
-10.35%
1J Leistung:
-2.78%
1-Tages-Spanne:
$61.65
$62.42
1-Wochen-Bereich:
$61.01
$62.84
52-Wochen-Spanne:
$54.52
$72.84
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Firmenname
Invesco Biotechnology Genome Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PBE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
62.28 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
277.22 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
563.51 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
566.17 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
220.85 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
485.93 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Aktie (PBE) Neueste Nachrichten
Envestnet Asset Management Inc. Sells 1,256 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Russell Investments Group Ltd. Grows Holdings in Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Russell Investments Group Ltd. - Defense World
Bank of Montreal Can Cuts Stock Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco S&P SmallCap Information Technology ETF (NASDAQ:PSCT) Shares Sold by Wells Fargo & Company MN - Defense World
Wells Fargo & Company MN Decreases Stake in Invesco Trust for Investment Grade Municipals (NYSE:VGM) - Defense World
Wells Fargo & Company MN Decreases Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
When (PBE) Moves Investors should Listen - news.stocktradersdaily.com
LPL Financial LLC Increases Position in ProShares Nasdaq-100 High Income ETF (NASDAQ:IQQQ) - Defense World
LPL Financial LLC Boosts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Raymond James Financial Inc. Purchases Shares of 18,878 Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Raymond James Financial Inc. Takes Position in PIMCO Municipal Income Fund III (NYSE:PMX) - Defense World
Commonwealth Equity Services LLC Has $1.73 Million Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
Biotech stocks and ETFs at a potential turning point - Fidelity
23andMe (NASDAQ: ME): Bankruptcy Filing and Strategic Sale Process - Value The Markets
(PBE) Trading Advice - Stock Traders Daily
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Jones Financial Companies Lllp Increases Stock Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
2Seventy Bio (TSVT): Surge Following Acquisition Announcement - Value The Markets
(PBE) Trading Signals - Stock Traders Daily
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value The Markets
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
How the (PBE) price action is used to our Advantage - news.stocktradersdaily.com
Moderna Faces Challenges, MRNA Stock Continues YTD Decline - Value the Markets
(PBE) Long Term Investment Analysis - Stock Traders Daily
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Top Canadian Genetics Stocks of 2025 - The Motley Fool Canada
Trading (PBE) With Integrated Risk Controls - Stock Traders Daily
(PBE) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Atara extends losses after FDA clinical hold - MSN
Is Invesco Building & Construction ETF (PKB) a Good Investment Right Now - espeaks.co.uk
Is the Invesco S&P 500 Equal Weight Technology ETF (RSPT) Worth Your Investment? - espeaks.co.uk
Broader population could benefit from Novartis spinal muscular atrophy treatment - MSN
Enhanced rat genome map identifies over 1,100 new protein-coding genes - MSN
(PBE) Investment Analysis and Advice - Stock Traders Daily
Jane Street Group LLC Makes New $295,000 Investment in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Sonic Healthcare (OTCMKTS:SKHHY) Stock Price Passes Above Fifty Day Moving Average – Should You Sell? - Defense World
Jane Street Group LLC Invests $295,000 in Morgan Stanley Direct Lending (NYSE:MSDL) - Defense World
Jane Street Group LLC Reduces Holdings in Fidelity Sustainable High Yield ETF (NYSEARCA:FSYD) - Defense World
Jane Street Group LLC Grows Position in Getty Images Holdings, Inc. (NYSE:GETY) - Defense World
Agenus Inc. (NASDAQ:AGEN) Stock Holdings Lessened by Jane Street Group LLC - Defense World
Jane Street Group LLC Has $258,000 Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World
AllianceBernstein (NYSE:AB) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
KeyCorp Forecasts Strong Price Appreciation for DoorDash (NASDAQ:DASH) Stock - Defense World
University City-Based Verismo Therapeutics Acquired by HLB Group of South Korea - MSN
6 Best Health Care ETFs to Buy for 2025 | Investing | U.S. News - Money/ US News
(PBE) Technical Pivots with Risk Controls - Stock Traders Daily
MML Investors Services LLC Sells 351 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
4,475 Shares in Direxion Daily Junior Gold Miners Index Bull 2X Shares (NYSEARCA:JNUG) Bought by HighTower Advisors LLC - Defense World
Fmr LLC Buys 519 Shares of Amplify AI Powered Equity ETF (NYSEARCA:AIEQ) - Defense World
Finanzdaten der Invesco Biotechnology Genome Etf-Aktie (PBE)
Es liegen keine Finanzdaten für Invesco Biotechnology Genome Etf (PBE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):